News Daily News Lorundrostat, an Aldosterone Synthase Inhibitor, Passes Phase II Hurdle Todd Neale September 12, 2023
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for February 2023 Shelley Wood March 01, 2023
News Daily News Erectile Dysfunction Drugs Show Cardioprotective Effects in Low-risk Men Yael L. Maxwell February 21, 2023